지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2018.1
- 수록면
- 179 - 185 (7page)
이용수
초록· 키워드
오류제보하기
Background: The continuous use of biologic agents in the treatment of psoriasis has been reported to result in successful and sustained therapeutic effects and safety. However, some patients choose intermittent and repetitive treatment. Objective: To determine the factors for selecting intermittent and repetitive ustekinumab treatment for the management of psoriasis. Methods: From January 2011 to October 2016, we enrolled 30 psoriasis patients who discontinued ustekinumab treatment and were followed up for psoriasis treatment. We reviewed data regarding patients’ clinical characteristics and the treatment they received, and investigated the factors for selecting intermittent treatment. Results: A total of 52 ustekinumab treatment periods were administered to the 30 patients. Of the 52 treatment periods, 34.6% were covered by insurance and 82.4% were discontinued after sufficient improvement had been made or at the patient’s request. Further analysis comparing the first and second ustekinumab treatments revealed that the patients who used ustekinumab in second treatment were more likely to be insured. In addition, the rate of patients reaching psoriasis area and severity index (PASI)75 and PASI90 was similar between the first and subsequent ustekinumab treatments. Conclusion: We found that the patients who used ustekinumab intermittently were those who were satisfied with the outcome of ustekinumab treatment but could not afford the treatment. These results suggested that economic burden can be a factor for the patients’ choice of short-term intermittent treatment. The expansion of insurance coverage can increase the effectiveness of, and patients’ satisfaction with, the management of psoriasis.
목차
등록된 정보가 없습니다.
참고문헌 (16)
참고문헌 신청
Nickoloff BJ / 2006 / What have we learned in dermatology from the biologic therapies? / J Am Acad Dermatol 54(3 Suppl 2):S143~S151
Fragoulis GE / 2016 / Therapeutic targeting of IL-17 and IL-23 cytokines in immune-mediated diseases / Annu Rev Med 67:337~353
Ramirez-Fort MK / 2013 / Continuous versus intermittent therapy for moderate-tosevere psoriasis / Clin Exp Rheumatol 31(4 Suppl 78):S63~S70
Kimball AB / 2012 / Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years / Br J Dermatol 166:861~872
Kimball AB / 2013 / Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study / J Eur Acad Dermatol Venereol 27:1535~1545
Fragoulis GE / 2016 / Therapeutic targeting of IL-17 and IL-23 cytokines in immune-mediated diseases / Annu Rev Med 67:337~353
Ramirez-Fort MK / 2013 / Continuous versus intermittent therapy for moderate-tosevere psoriasis / Clin Exp Rheumatol 31(4 Suppl 78):S63~S70
Kimball AB / 2012 / Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years / Br J Dermatol 166:861~872
Kimball AB / 2013 / Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study / J Eur Acad Dermatol Venereol 27:1535~1545
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
건선의 한방치험 3례 - 보골지추출물을 병행하여
한방안이비인후피부과학회지
2018 .01
-
氣虛를 동반한 건선 환자 치험 2례
대한한의학회지
2016 .03
-
Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study)
Annals of Dermatology
2023 .04
-
Comparison of Treatment Goals for Moderate-to-Severe Psoriasis between Korean Dermatologists and the European Consensus Report
Annals of Dermatology
2015 .01
-
한의약 치료로 호전된 홍피성 건선 환자 치험 3례
한방안이비인후피부과학회지
2019 .01
-
Prevalence of Psoriasis in Korea: A Population-Based Epidemiological Study Using the Korean National Health Insurance Database
Annals of Dermatology
2017 .01
-
기능성 위장장애를 동반한 건선 환자 치험 2례
한방안이비인후피부과학회지
2015 .01
-
건선의 치료 접근법에 대한 고찰 및 제언
한방안이비인후피부과학회지
2020 .01
-
The Association between Psoriasis Area and Severity Index and Cardiovascular Risk Factor in Korean Psoriasis Patients
Annals of Dermatology
2016 .01
-
Treatment of Psoriasis with Exudation : Three Case Studies
대한한의학회지
2016 .06
-
急性扁桃炎 이후 발생한 乾癬 환자 치험 4 례
대한한의학회지
2015 .09
-
만성신부전이 동반된 판상건선 환자의 생물학적제제 치료 3예
대한건선학회지
2021 .06
-
건선 환자 101명의 6개월간의 한의학적 치료효과에 대한 후향적 연구
한방안이비인후피부과학회지
2017 .01
-
Clinical Characteristics of Psoriasis for Initiation of Biologic Therapy: A Cluster Analysis
Annals of Dermatology
2023 .04
-
건선 환자에서 생물학적 제제의 치료 순응도에 대한 단일기관, 후향적 연구
대한건선학회지
2024 .06
-
Validity of Diagnostic Codes for Identification of Psoriasis Patients in Korea
Annals of Dermatology
2020 .01
-
The Clinical Profile of Patients with Psoriasis in Korea: A Nationwide Cross-Sectional Study (EPI-PSODE)
Annals of Dermatology
2017 .01
-
중등도와 중증의 건선환자에서 생물학제제 치료 후 치료 만족도에 대한 평가
대한건선학회지
2021 .12
-
한약으로 치료 받은 건선 환자 107명의 안전성 및 유효성에 대한 고찰
대한한의학회지
2016 .03
이 논문의 저자 정보
최근 본 자료
댓글(0)
0